Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • INVENTIV HEALTH INC Analyst Recommendations

  • Analyst Consensus: VTIV

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.000 Buy 4
    30 Days Ago 2.000 Buy 4
    60 Days Ago 2.400 Buy 5
    90 Days Ago 2.400 Buy 5
    120 Days Ago 2.400 Buy 5

  • Analyst Ratings: VTIV

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Auriga U.S.A — Buy 10/15/2009 21.00
    Jefferies & Co — Hold 10/13/2009 16.00
    Auriga U.S.A — Buy 02/27/2009 14.00
    Caris & Company — Above Average 02/05/2009 15.00
    Barclays Capital — Overweight 01/26/2009 15.00
    Jefferies & Co Buy Hold 12/23/2008 11.00
    Auriga U.S.A — Buy 12/17/2008 18.00
    Caris & Company Average Above Average 11/07/2008 18.00
    Caris & Company Above Average Average 08/08/2008 20.00
    Broadpoint Capital — Strong Buy 11/08/2007 42.00
    Caris & Company — Above Average 11/07/2007 47.00
    Caris & Company — Above Average 10/05/2007 50.00
    Lehman Brothers — Overweight 08/09/2007 44.00
    Jefferies & Co Hold Buy 07/27/2007 42.00
    First Albany Buy Strong Buy 06/14/2007 —
    Lehman Brothers — Overweight 02/28/2007 41.00
    First Albany — Buy 02/20/2007 45.00
    Banc of America Sec — Buy 02/07/2007 39.00
    Lehman Brothers — Overweight 12/27/2006 37.00
    First Albany — Buy 12/04/2006 41.00
    First Albany — Buy 11/29/2006 —
    Jefferies & Co Buy Hold 10/04/2006 32.00
    Banc of America Sec — Buy 05/10/2006 37.00
    Lehman Brothers — Overweight 10/12/2005 33.00
    CIBC Wrld Mkts Sector Perform Sector Outperform 05/04/2005 —
    Caris & Company Above Average Buy 04/26/2005 —
    Caris & Company — Above Average 04/05/2005 —
    CIBC Wrld Mkts — Sector Perform 03/28/2005 27.00
    Roth Capital — Strong Buy 01/05/2005 28.00
    Roth Capital — Strong Buy 10/18/2004 27.00
    Next